Company Research
Whether you are exploring new sales opportunities or researching a new investment, FirstRain provides unique insight into important developments for Johnson & Johnson (JNJ). You can receive reports or configure the research engine for yourself.
Report On:
Johnson & Johnson (JNJ)
HEALTHCARE - Drugs - Drug Manufacturers - Major
Generated: Thursday September 15, 2011 04:14 AM
|
|
||||||||||||||||||
Quotes About Johnson & Johnson
-
Update: Transvaginal mesh makers debate patient groups at the FDA advisory panel
There are clear risks associated with the transvaginal placement of mesh to treat POP,"
- William Maisel -
Johnson & Johnson mulls heart device biz
Both [technologies] are interesting. We are interested in looking at them,"
- Dominic Caruso -
Boston Scientific Gets New Boss, Eventually (BSX, JNJ, ABT)
transition period is being implemented to accommodate Mahoney's post-employment obligations to Johnson & Johnson, which both Boston Scientific and Johnson & Johnson have agreed is appropriate." -
Johnson & Johnson Symposium Honors 2011 Recipient of The Dr. Paul Janssen Award for Biomedical Research
Dr. Ferrara's groundbreaking research has made a direct impact on the quality of life of many thousands of people,"
- Paul Stoffels -
J&J Veteran to Lead Boston Scientific
I was pleasantly surprised by the hire,"
- Jan Wald
No Comment
-
J&J pleads guilty in Natrecor marketing case
The drugmaker declined to comment beyond saying in a statement that the U.S. Department of Justice charged Scios with a single misdemeanor violation of the Food, Drug and Cosmetic Act.
- Deena Beasley
-
For J&J and Boston Scientific, a Curious CEO Pick Marks a Ceasefire
Of course J&J, which declined to comment on the speculation, is in the process of closing on a $21.3 billion acquisition of another device company, Synthes .
- Larry Biegelsen
-
J&J Veteran to Lead Boston Scientific
A Boston Scientific spokesman said Mahoney was not available for interviews on Tuesday because he is not an employee yet.
- Jan Wald
Latest Company Intelligence
-
The Importance Of Due Diligence (Exemplified By Johnson & Johnson)
Seeking Alpha | Sep 15,'11
You have seen the phrase, “Do your own due diligence before investing” many times. We will explore what due diligence means and how you might exercise it in the selection and purchase of securities. What Does Due Diligence Mean? In its simplest terms it means the care that a reasonable and prudent person takes in doing an investigation before making a decision. If you have -
J&J Pays $85M Fine Over Natrecor Marketing
Pharmalot | Sep 14,'11
The Scios unit of Johnson & Johnson Scios has agreed to pay an $85 million fine and pleaded guilty to a msidemeanor for misbranding the Natrecor acute heart failure drug. The drugmaker was accused of providing labeling that “lacked adequate directions for use” between 2001 and 2005 (read the plea agreement here ). The move comes two years after prosecutors began considering whether to -
For J&J and Boston Scientific, a Curious CEO Pick Marks a Ceasefire
Health Blog - The Wall Street Journal | Sep 14,'11
We confess our eyebrows went up here at Health Blog headquarters when news crossed the wires late yesterday that Johnson & Johnson's top medical-device exec Michael Mahoney was named president and will eventually be CEO at beleaguered Boston Scientific . The word “rivalry” is hardly sufficient to describe the bare-knuckled hostility that has characterized relations between the two -
Stuck On Johnson & Johnson Despite Consumer Products Recalls
Seeking Alpha | Sep 14,'11
In a recent interview , Johnson & Johnson ( JNJ ) CEO William Weldon discussed some of the problems facing JNJ and his vision for getting through the recalls and manufacturing problems that have led to products such as Children's Tylenol and Motrin being pulled from shelves and replaced in consumers' medicine cabinets by private label products. With uncertainty from the Consumer Products -
Boston Scientific Gets New Boss, Eventually (BSX, JNJ, ABT)
24/7 Wall St | Sep 14,'11
Medical device maker Boston Scientific Corp. (NYSE: BSX) has named a new president who will take over on October 17th and who will then be elevated to CEO on November 1, 2012. Was Boston Scientific's board dozing when it agreed to this? The lucky guy is Michael Mahoney, who is currently Worldwide Chairman of the Medical Device and Diagnostics group at Johnson & Johnson (NYSE: JNJ). -
Boston Scientific turns to rival for new CEO
The BBJ's Morning Roundup - Bizjournals | Sep 14,'11
Boston Scientific (NYSE: BSX) has tapped Johnson & Johnson executive Michael Mahoney as its new CEO. Chief executive Ray Elliott announced his pending retirement in May. Boston Scientific Corp. Boston Scientific Corp. Latest from The Business Journals Boston Sci picks J&J exec for new CEO Boston Scientific picks J&J executive as next CEO Stents don't stop strokes in study Follow this
FirstRain customers use intelligent business search to find actionable insights about companies, management, and industries. You can review company briefs, quickly research a new idea or opportunity, generate personalized industry reports, or set up alerts on reasons to call. Be sure to view our sample reports below.
